COPDMAP, as part of the MRC/ABPI Inflammation and Immunology Initiative, represents the first phase of a new approach in funding by the MRC, bringing together academics and industry at the early R&D stages to develop a stratified approach to disease (targeting the right treatments to the right people), enabling effective clinical trials as well as identifying novel biomarkers, mechanisms and targets.

Learn more »

Work packages

Brief details of the four work packages in COPDMAP

View details »


COPDMAP brings togther partners from academia, healthcare and industry

View a list of partners »

Internal (partners only)

Internal management platform

SYNRGY management platform »

Patient / visit / sample tracking system

Sample tracking platform



Contact us

Please make all enquiries to